Ltd.;Ariel - University Research and Development Company
发明人:
ANAVI-GOFFER, Sharon,GERTSCH, Juerg
申请号：
EP14785401
公开号：
EP2986587A4
申请日:
2014.04.16
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention provides cannabinoid type 2 (CB2) receptor inverse agonists for treating or ameliorating psychiatric disorders. The present invention further provides pharmaceutical compositions comprising 4′-O-methylhonokiol for treating Attention Deficit Hyperactivity Disorder (ADHD) and Tourette's syndrome.
